Company intelligence / Profile preview

Genomatica

San Diego, California, United Statesgenomatica.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Genomatica has commercialized multiple sustainable materials technologies that replace fossil fuel-derived chemicals with plant-based alternatives. Its flagship product, GENO™ BDO, has been produced at industrial scale since at least 2016. The company’s processes enable up to a ~90% reduction in carbon emissions compared to conventional methods. It partners with major global brands to supply renewable chemical building blocks used in plastics, textiles, cosmetics, cleaning products, and more.

Therapeutic areas: Other
Modalities: None
Industry: Non-Drug Biotech

Partnerships

NovamontQore® joint venture of Cargill and HELMCovestroAsahi KaseiUnilever ($120 million palm oil alternative JV)

Beyond the preview

Go deeper on Genomatica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genomatica.

Explore the full profile